![Dow and broader stock-market futures turn positive amid upbeat report on Gilead’s experimental coronavirus treatment Dow and broader stock-market futures turn positive amid upbeat report on Gilead’s experimental coronavirus treatment](https://mynews24x7.in/wp-content/uploads/;https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg)
[ad_1]
U.S. stock-index futures turned positive on Friday after a report from Gilead Sciences indicated that its experimental treatment for coronavirus was seeing positive results in reducing deaths. Futures for the Dow Jones Industrial Average
YM00,
YMU20,
were up 0.1% at 25,600, those for the S&P 500 index
ES00,
ESU20,
were trading up 0.1% at 3,144, while Nasdaq-100 futures
NQ00,
NQU20,
advanced 0.1% at 10,740. Gilead published a report on Friday saying that its antiviral drug remdesivir showed that it reduced the risk of death for coronavirus patients by 62% compared with standard care alone.
The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.
[ad_2]
Source link